Drug Shortage Report for PMS-BUPRENORPHINE-NALOXONE
Report ID | 17805 |
Drug Identification Number | 02424878 |
Brand name | PMS-BUPRENORPHINE-NALOXONE |
Common or Proper name | BUPRENORPHINE/NALOXONE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | BUPRENORPHINE NALOXONE |
Strength(s) | 8MG 2MG |
Dosage form(s) | TABLET |
Route of administration | SUBLINGUAL |
Packaging size | 30 |
ATC code | N07BC |
ATC description | DRUGS USED IN ADDICTIVE DISORDERS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-08-01 |
Estimated end date | 2017-11-30 |
Actual end date | 2017-11-22 |
Shortage status | Resolved |
Updated date | 2017-11-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-11-23 | French | Compare |
v6 | 2017-11-23 | English | Compare |
v5 | 2017-09-06 | French | Compare |
v4 | 2017-09-06 | English | Compare |
v3 | 2017-08-02 | English | Compare |
v2 | 2017-08-01 | French | Compare |
v1 | 2017-08-01 | English | Compare |
Showing 1 to 7 of 7